Compare iShares 1 3 Year Treasury Bond ETF (SHY) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares 1 3 Year Treasury Bond ETF vs Twist Bioscience Corp — how do they compare? iShares 1 3 Year Treasury Bond ETF trades at $81.89, while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Twist Bioscience Corp is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| SHY | TWST | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $83.18 | $102.88 |
52-Week Low | $81.79 | $24.16 |
Market Cap | — | $5.45B |
Enterprise Value | — | $5.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SHY, a US stock, trades at $81.955, down 0.04% on the day. Technical indicators show a bullish overall signal with bearish moving averages and neutral oscillators, while key support and resistance levels cluster around $82. Recent corporate actions include scheduled dividend payments of $0.24 per share through mid-2026, indicating stable income distribution.
The outlook for SHY is mixed, with technical momentum facing near-term resistance. Investment opportunities center on dividend consistency, but risks include market volatility and sensitivity to interest rate changes. Investors should weigh income stability against potential price stagnation amid evolving macroeconomic conditions.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
